Trial Profile
Phase I trial investigating the tolerability of elpamotide
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Oct 2010
Price :
$35
*
At a glance
- Drugs Elpamotide (Primary)
- Indications Biliary cancer; Pancreatic cancer
- Focus Adverse reactions
- Sponsors Fuso Pharmaceutical Industries; OncoTherapy Science
- 27 Apr 2006 New trial record.